Antiviral Research

Article	Citations
Antiviral activities of type I interferons to SARS-CoV-2 infection	341
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern	321
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions	236
Hepatitis B virus biology and life cycle	171
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2	116
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors	115
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2	106
Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential	100
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19	96
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters	94
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase	70
Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B	67
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes	63
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020	52
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral	49
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents	49
Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E	47
Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation	47
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice	46
Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses	45
Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro	44
Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro	44
Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies	43
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro	43
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis	43

Mechanisms of HBV immune evasion	42
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection	39
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection	37
Burden of influenza B virus infection and considerations for clinical management	36
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2	36
HBV replication inhibitors	36
Current knowledge on Hepatitis Delta Virus replication	35
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development	35
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo	34
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection	34
Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations	34
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2	34
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry	33
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system	33
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir	32
Cinnamic acid inhibits Zika virus by inhibiting RdRp activity	32
Betulinic acid exhibits antiviral effects against dengue virus infection	31
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection	30
Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening	29
HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals	29
A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms	28
Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING/TBK1/P62 pathway	28
Diketo acids inhibit the cap-snatching endonuclease of several Bunyavirales	28
Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production	27
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group	27
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro	27
The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo	27
Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding	26
E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation	26
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors	26
ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity	26
Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques	25
Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection	25
Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation	25
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues	25
Clinical outcome and the role of antivirals in congenital cytomegalovirus infection	24
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera	24
Influenza antivirals and their role in pandemic preparedness	24
Allosteric inhibitors of the main protease of SARS-CoV-2	24
Iminosugars: A host-targeted approach to combat Flaviviridae infections	23
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening	23
Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis	23
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro	23
Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses	22
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication	22
Targeting host DEAD-box RNA helicase DDX3X for treating viral infections	21
Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway	21
Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus	21
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro	21
Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B	21

Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augm	21
Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target	20
Immunobiology of Crimean-Congo hemorrhagic fever	20
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference	19
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies	19
S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants	19
Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment	19
Failure to bictegravir and development of resistance mutations in an antiretroviral-experienced patient	19
Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking	19
New methylene blue derivatives suggest novel anti-orthopoxviral strategies	19
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase	19
14-Deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to	19
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2	18
A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance	18
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease	18
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis	18
Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses	18
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening	17
Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir	17
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge	17
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2	17
Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study	17
The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection	16
A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon	16
Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory	16
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier	16
Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs	15
Reverse genetic systems of SARS-CoV-2 for antiviral research	15
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis	15
Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage	15
Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts	15
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein	15
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys	15
NK-lysin peptides ameliorate viral encephalopathy and retinopathy disease signs and provide partial protection against nodavirus infection in European sea bass	15
Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90	15
Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio)	15
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro	15
Conserved coronavirus proteins as targets of broad-spectrum antivirals	15
Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors	15
Animal models for the study of human hepatitis B and D virus infection: New insights and progress	15
A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection	15
Anti-flavivirus activity of polyoxometalate	14
Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses	14
Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018–2019 season and detection of variant influenza a viruses with polymerase acidic subun	14
Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3	14
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses	14
A dengue type 2 reporter virus assay amenable to high-throughput screening	14
Artificial intelligence: Machine learning approach for screening large database and drug discovery	14
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1	14
The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium	14
Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors	14
Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses	14
In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2	14
Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods	14
Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry	14
Enzymatically synthesized 2′-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity	14
ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern	14
Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor	13
Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses	13
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants	13
Target verification of artesunate-related antiviral drugs: Assessing the role of mitochondrial and regulatory proteins by click chemistry and fluorescence labeling	13
Generation of a reporter yellow fever virus for high throughput antiviral assays	13
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig	13
Hepatitis D virus: Improving virological knowledge to develop new treatments	13
Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates	13
Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice	13
A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia	12
Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein	12
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency	12
Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins	12
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines	12
Potential application of antiviral coumarin in aquaculture against IHNV infection by reducing viral adhesion to the epithelial cell surface	12
Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo	12
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model	11
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization	11
Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators	11
Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing	11
The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses	11
Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP	11
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method	11

Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model	11
TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity	11
GS-441524 inhibits African swine fever virus infection in vitro	11
LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug	11
In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus	11
Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease	11
Infectious bronchitis virus: Identification of Gallus gallus APN high-affinity ligands with antiviral effects	11
BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines	11
Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species	11
Viral replicon particles protect IFNAR−/− mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination	11
Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review	11
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production	10
The involvement of annexin A1 in human placental response to maternal Zika virus infection	10
Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy	10
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein	10
JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms	10
Adefovir dipivoxil efficiently inhibits the proliferation of pseudorabies virus in vitro and in vivo	10
Flavivirus NS4B protein: Structure, function, and antiviral discovery	10
Inhibiting cytomegalovirus replication through targeting the host electron transport chain	10
Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs	10
An efficient method for simultaneously screening for HIV, syphilis, and HCV based on one dried blood spot sample	10
Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses	10
Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection	10
A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection	10
Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation	10
Relative frequency of cytomegalovirus UL56 gene mutations detected in genotypic letermovir resistance testing	10
BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals	10
Development and characterization of recombinant tick-borne encephalitis virus expressing mCherry reporter protein: A new tool for high-throughput screening of antiviral compounds, and neutralizing ant	10
Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons	10
Metabolic regulation of the HBV-specific T cell function	10
Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus	10
Generation of a VeroE6 Pgp gene knock out cell line and its use in SARS-CoV-2 antiviral study	10
Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model	10
Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination w	9
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors	9
Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice	9
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics	9
Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation	9
Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins	9
Broad spectrum compounds targeting early stages of rabies virus (RABV) infection	9
Therapeutics for flaviviral infections	9
A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition	9
Remdesivir inhibits the polymerases of the novel filoviruses Lloviu and Bombali virus	9
Vector-borne viruses in Turkey: A systematic review and bibliography	9
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors	9
Targeting SARS-CoV-2 and host cell receptor interactions	9
Reliable quantification of Cytomegalovirus DNAemia in Letermovir treated patients	9
Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling	9
Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022	9
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection	9
New directions in the experimental therapy of tick-borne encephalitis	9
miRNAs derived from milk small extracellular vesicles inhibit porcine epidemic diarrhea virus infection	9
Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model	9
Lipid balance remodelling by human positive-strand RNA viruses and the contribution of lysosomes	8
Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis	8
ML-SA1 and SN-2 inhibit endocytosed viruses through regulating TRPML channel expression and activity	8
Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design	8
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening	8
SERS based rapid and ultrasensitive detection of Japanese Encephalitis Virus	8
Dengue NS1 induces phospholipase A2 enzyme activity, prostaglandins, and inflammatory cytokines in monocytes	8
Pinostrobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism	8
Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019–2020 season in Japan and detection of influenza virus with the PA E23K substitution	8
Unexpected complete recovery of a patient with severe tick-borne encephalitis treated with favipiravir	8
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication	8
Increased ILT2 expression contributes to dysfunction of CD56dimCD16+NK cells in chronic hepatitis B virus infection	8
Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir	8
Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells	8
Virological and clinical outcomes in outpatients treated with baloxavir or oseltamivir: A Japanese multicenter study in the 2019–2020 influenza season	8
Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed −1 ribosomal frameshifting	8
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2	8
Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase	8
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro	8
The life cycle of the alphaviruses: From an antiviral perspective	8
Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients	8
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication	8
Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein	8
Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects	8
Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters	8
Hemin protects against Zika virus infection by disrupting virus-endosome fusion	8
N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response	8
Interference of dengue replication by blocking the access of 3′ SL RNA to the viral RNA-dependent RNA polymerase	8
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides	8
7-Deaza-7-fluoro-2′-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation	8
Conserved use of the sodium/bile acid cotransporter (NTCP) as an entry receptor by hepatitis B virus and domestic cat hepadnavirus	8
Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models	8
Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy	8
Quindoline-derivatives display potent G-quadruplex-mediated antiviral activity against herpes simplex virus 1	7
Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792	7
Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404	7
The calcium channel inhibitor lacidipine inhibits Zika virus replication in neural progenitor cells	7
Advancing Marburg virus antiviral screening: Optimization of a novel T7 polymerase-independent minigenome system	7
Identification of a novel acylthiourea-based potent broad-spectrum inhibitor for enterovirus 3D polymerase in vitro and in vivo	7
Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir	7
Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry	7
Inhibition of endocytosis of porcine reproductive and respiratory syndrome virus by rottlerin and its potential prophylactic administration in piglets	7